Seer, Inc. (California) (SEER)
2.04
+0.01
(+0.49%)
USD |
NASDAQ |
Aug 24, 16:00
2.04
0.00 (0.00%)
After-Hours: 20:00
Seer Shareholders Equity (Quarterly) : 225.68M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 225.68M |
| March 31, 2026 | 241.48M |
| December 31, 2025 | 259.31M |
| September 30, 2025 | 271.81M |
| June 30, 2025 | 288.29M |
| March 31, 2025 | 311.01M |
| December 31, 2024 | 327.57M |
| September 30, 2024 | 344.73M |
| June 30, 2024 | 364.70M |
| March 31, 2024 | 383.56M |
| December 31, 2023 | 396.90M |
| September 30, 2023 | 405.68M |
| June 30, 2023 | 418.12M |
| March 31, 2023 | 432.99M |
| Date | Value |
|---|---|
| December 31, 2022 | 446.99M |
| September 30, 2022 | 457.77M |
| June 30, 2022 | 472.04M |
| March 31, 2022 | 486.46M |
| December 31, 2021 | 502.92M |
| September 30, 2021 | 515.20M |
| June 30, 2021 | 526.04M |
| March 31, 2021 | 535.77M |
| December 31, 2020 | 431.61M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 87.68M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Champions Oncology, Inc. | 3.939M |
| Medpace Holdings, Inc. | 433.86M |
| Avantor, Inc. | 5.630B |
| Personalis, Inc. | 235.16M |
| Adaptive Biotechnologies Corp. | 142.91M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 256.64M |
| Total Liabilities (Quarterly) | 30.96M |
| Debt to Equity Ratio | 0.0992 |
| Current Ratio | 14.74 |
| Net Debt Paydown Yield | 0.66% |